Insmed Shares Surge ~30% on Explosive BRINSUPRI Launch and Massive Guidance Raise

Insmed delivered a standout Q2 with $425.5M revenue driven by $309M BRINSUPRI sales. Company raised 2026 guidance and long-term peak sales to $14B+.